Literature DB >> 19355971

Regulation of matrix synthesis, remodeling and accumulation in glomerulosclerosis.

Ambra Pozzi1, Paul A Voziyan, Billy G Hudson, Roy Zent.   

Abstract

After injury the body normally undergoes a repair process, however when this event becomes deregulated the pathological condition of fibrosis occurs. There are many similarities with respect to the fundamental mechanisms that regulate sclerosis in different organ systems. In this review we utilize the pathological entity of glomerulosclerosis in the kidney to highlight some of the general paradigms whereby extracellular matrix (ECM) is deposited in greater quantities than it is degraded. Our review discusses how genetic and structural abnormalities of specific ECM components can result in fibrosis. In addition, we outline how some key growth factors, integrins and oxidative stress play a role in the development of glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355971     DOI: 10.2174/138161209787846748

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  19 in total

1.  Pyridoxamine protects proteins from damage by hypohalous acids in vitro and in vivo.

Authors:  Hartman Madu; Josh Avance; Sergei Chetyrkin; Carl Darris; Kristie Lindsey Rose; Otto A Sanchez; Billy Hudson; Paul Voziyan
Journal:  Free Radic Biol Med       Date:  2015-07-06       Impact factor: 7.376

2.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  Inhibition of integrin α2β1 ameliorates glomerular injury.

Authors:  Corina M Borza; Yan Su; Xiwu Chen; Ling Yu; Stacey Mont; Sergei Chetyrkin; Paul Voziyan; Billy G Hudson; Paul C Billings; Hyunil Jo; Joel S Bennett; William F Degrado; Beate Eckes; Roy Zent; Ambra Pozzi
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

4.  Enhancing integrin α1 inserted (I) domain affinity to ligand potentiates integrin α1β1-mediated down-regulation of collagen synthesis.

Authors:  Mingjian Shi; Vadim Pedchenko; Briana H Greer; Wade D Van Horn; Samuel A Santoro; Charles R Sanders; Billy G Hudson; Brandt F Eichman; Roy Zent; Ambra Pozzi
Journal:  J Biol Chem       Date:  2012-08-10       Impact factor: 5.157

5.  Purple corn anthocyanins retard diabetes-associated glomerulosclerosis in mesangial cells and db/db mice.

Authors:  Jing Li; Min-Kyung Kang; Jin-Kyu Kim; Jung-Lye Kim; Sang-Wook Kang; Soon Sung Lim; Young-Hee Kang
Journal:  Eur J Nutr       Date:  2011-11-20       Impact factor: 5.614

Review 6.  The role of cell-extracellular matrix interactions in glomerular injury.

Authors:  Corina M Borza; Ambra Pozzi
Journal:  Exp Cell Res       Date:  2012-03-05       Impact factor: 3.905

Review 7.  Assembly of fibronectin extracellular matrix.

Authors:  Purva Singh; Cara Carraher; Jean E Schwarzbauer
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

Review 8.  Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View.

Authors:  Corina M Borza; Xiwu Chen; Roy Zent; Ambra Pozzi
Journal:  Curr Top Membr       Date:  2015       Impact factor: 3.049

Review 9.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

10.  The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.

Authors:  Manuel Chiusa; Wen Hu; Hong-Jun Liao; Yan Su; Corina M Borza; Mark P de Caestecker; Nataliya I Skrypnyk; Agnes B Fogo; Vadim Pedchenko; Xiyue Li; Ming-Zhi Zhang; Billy G Hudson; Trayambak Basak; Roberto M Vanacore; Roy Zent; Ambra Pozzi
Journal:  J Am Soc Nephrol       Date:  2019-08-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.